May 12, 2021

an update from the Comparing COVID-19 Vaccine Schedule Combinations (Com-COV) study

Matthew Snape, lead investigator on the Com-COV study, updated science journalists on some early reactogenicity results and answered their questions about the findings. The correspondence article has been published in the Lancet.

Speakers included:

Prof Matthew Snape, Associate Professor in paediatrics and vaccinology, Oxford Vaccine Group, Chief Investigator on the trial